Sernova Biotherapeutics Inc
SEOVF
$0.146
$0.00382.67%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.01M | -3.64M | -5.50M | -7.33M | -7.22M |
| Total Depreciation and Amortization | 33.50K | 124.80K | 118.90K | 75.80K | 77.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 497.70K | -427.10K | 549.00K | 520.30K | 533.80K |
| Change in Net Operating Assets | 79.70K | 1.07M | 2.29M | 1.40M | 3.46M |
| Cash from Operations | -3.40M | -2.87M | -2.55M | -5.33M | -3.15M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 3.68M | 2.95M | 1.54M |
| Cash from Investing | -- | 0.00 | 3.68M | 2.95M | 1.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -42.50K | -42.00K | -42.00K | -42.00K | -43.10K |
| Issuance of Common Stock | -- | 5.21M | 0.00 | 15.80K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 64.80K | -253.50K | 68.40K | 193.00K | -- |
| Cash from Financing | 15.70K | 3.60M | 19.20K | 122.90K | -32.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.38M | 727.30K | 1.15M | -2.26M | -1.64M |